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Background: The global economic crisis has been associated with increased unemployment, reduced health-care
spending and adverse health outcomes. Insights into the impact of economic variations on cancer mortality,
however, remain limited. Methods: We used multivariate regression analysis to assess how changes in unemploy-
ment and public-sector expenditure on health care (PSEH) varied with female breast cancer mortality in the 27
European Union member states from 1990 to 2009. We then determined how the association with unemployment
was modified by PSEH. Country-specific differences in infrastructure and demographic structure were controlled
for, and 1-, 3-, 5- and 10-year lag analyses were conducted. Several robustness checks were also implemented.
Results: Unemployment was associated with an increase in breast cancer mortality [P<0.0001, coefficient
(R) = 0.1829, 95% confidence interval (CI) 0.0978–0.2680]. Lag analysis showed a continued increase in breast
cancer mortality at 1, 3, 5 and 10 years after unemployment rises (P<0.05). Controlling for PSEH removed this
association (P=0.063, R = 0.080, 95% CI 0.004 to 0.163). PSEH increases were associated with significant decreases
in breast cancer mortality (P<0.0001, R = –1.28, 95% CI 1.67 to 0.877). The association between unemployment
and breast cancer mortality remained in all robustness checks. Conclusion: Rises in unemployment are associated
with significant short- and long-term increases in breast cancer mortality, while increases in PSEH are associated
with reductions in breast cancer mortality. Initiatives that bolster employment and maintain total health-care
expenditure may help minimize increases in breast cancer mortality during economic crises.
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Introduction
The present economic crisis has profoundly affected the EuropeanUnion (EU), with persistently high unemployment rates and
concerns over the effects of such crises on population health.1 In
response to the economic crisis, several governments have imple-
mented fiscal consolidation measures. In countries that have seen
unemployment rates increase substantially from 2006 (before the
crisis) to 2013 (Figure 1), public-sector spending cuts have been
sizeable, which, in turn, have contributed to further rises in un-
employment.2 On an individual level, long-term unemployment
and loss of employment have been linked to a multitude of
unhealthy behaviours, increased suicide rates and reduced access
to care.3–5 Recent work has also demonstrated that fiscal consolida-
tion measures are associated with significant reductions in public-
sector expenditure on health care (PSEH).6 Such changes raise the
question of how economic variations, outside and within crises,
affect health outcomes.
Ecological studies exploring health-economic trends have thus far
focussed predominantly on non-neoplastic outcomes, such as
suicide rates, cardiovascular disease incidence and all-cause
mortality.7–11 As a result, insights into the relationship between
macroeconomic changes and cancer remain limited.
Breast cancer is the largest cause of female cancer mortality in the
EU, with an estimated 89 000 deaths in 2013.12 Deprivation and
lower socio-economic status (SES), to which long-term unemploy-
ment may contribute,13 have been associated with increased breast
cancer mortality in individuals.14 In the short term, lower SES is
associated with increased cancer mortality15 due in part to reduced
access to treatment.16 In the long term, more deprived women are
more likely to be diagnosed at a later stage owing to a lower
likelihood of attending screening, for example,17 as well as being
less likely to attend follow-up, and thus entailing a greater risk of
mortality. Recent work, for example, has shown that substantial
reductions in 5-year breast cancer mortality can be achieved by
eliminating deprivation differences in stage at diagnosis.14
Given this relationship between long-term unemployment, low
SES and breast cancer mortality, we evaluated, at the macroeco-
nomic level, how changes in unemployment and PSEH varied with
female breast cancer mortality, over a 20-year period in the EU.
Unemployment changes and PSEH were chosen primarily for their
reliability as macroeconomic indicators, high data availability and,
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in the case of unemployment, the ability to capture actual changes
in circumstances at the level of the individual. Moreover, there is
evidence to suggest a link between changes in unemployment and
health outcomes at the aggregate and individual levels.2,4 In what we
believe to be the first study of its kind, we aimed to provide a better
understanding of the link between macroeconomic changes and
breast cancer.
Methods
Data collection
Female breast cancer mortality data (deaths per 100 000) were
obtained from the World Health Organization (WHO) mortality
database.18 Data were available for years 1990–2009. WHO
mortality data are obtained via death certification and are
annually collected from civil registration systems of WHO
member states. The quality of the data has been evaluated by the
WHO.19 Macroeconomic data were obtained from the World Bank’s
Development Indicators and Global Development Finance 2013
edition.20 Public-sector debt as a percentage of gross domestic
product (GDP) data was obtained from the International
Monetary Fund (IMF) Historical Public Debt Database.21 Data
were analysed for the 27 EU member states (Table 1), but only for
the years when these countries were members of the EU. Because our
analysis explored 1990–2009, Croatia—which joined in the EU in
2013—was excluded. Unemployment, as defined by the World Bank
(data code: SL.UEM.TOTL.ZS),20 was taken to be the share of the
labour force that is without work but available and seeking
employment. PSEH (data code: SH.XPD.PUBL.ZS) was measured
as a percentage of GDP, and was defined by the World Bank as
including all rent and capital spending from government budgets
(central and local), external borrowings and grants (including
donations from international agencies and non-governmental
organizations) and social (or compulsory) health insurance funds.
Statistical analysis
Multivariate regression analysis was used to assess the relationship
between breast cancer mortality (response variable) and unemploy-
ment (predictor variable). To ensure that results were not driven by
extreme observations for certain countries, a fixed-effects approach
was used in the regression models, including 27 dummy variables for
the 27 countries in the dataset. Doing this means that the model
evaluates mortality changes within individual countries while
holding constant time-invariant differences between countries
including higher predispositions to breast cancer, as well as
political, cultural and structural differences. Such time-invariant het-
erogeneity was also controlled for by using a panel-data approach to
compare unemployment rates or PSEH with the mortality rates in
each country; something that aggregate, time-series analyses fail to
do. This conservative modelling approach makes the data more
Figure 1 Unemployment rate (%) in selected EU countries, 2006 and 2013. Unemployment rates have risen from 2006 to 2013 in these
countries. Source: European Commission. EUROSTAT. European Commission, 2013 (AccessedDecember 29, 2013, atepp.eurostat.ec.europa.eu).
Table 1 Unemployment and breast cancer mortality levels in the
EU, 2009
Country Year
joining EU
Unemployment
2009
Breast cancer
mortality 2009
Austria 1995 4.8 15.3
Belgium 1973 7.9 19.1
Bulgaria 2007 6.8 14.9
Cyprus 2004 5.3 0
Czech Republic 2004 6.7 13.6
Denmark 1973 6 19.4
Estonia 2004 13.8 15.5
Finland 1995 8.2 13.4
France 1957 9.1 16.6
Germany 1957 7.7 16.3
Greece 1981 9.5 14
Hungary 2004 10 19.6
Ireland 1973 11.7 19.1
Italy 1957 7.8 15.8
Latvia 2004 17.1 17.8
Lithuania 2004 13.7 17
Luxembourg 1957 5.1 16.3
Malta 2004 6.9 24.5
Netherlands 1957 3.4 18.5
Poland 2004 8.2 14.1
Portugal 1986 9.5 13.9
Romania 2007 6.9 15.7
Slovak Republic 2004 12.1 5.2
Slovenia 2004 5.9 16.8
Spain 1986 18 12.2
Sweden 1995 8.3 13.1
United Kingdom 1973 7.7 17.3
Sources: Breast cancer mortality per 100 000. World Health
Organization Mortality Data and Statistics; http://www.who.int/
healthinfo/statistics/mortality/en/index.html
Economic and population data. World Bank Development
Indicators 2013; http://data.worldbank.org/data-catalog/world-
development-indicators
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comparable. The demographic structure of the selected countries
was controlled for by incorporating total population size in
addition to the percentage of the population aged >65 and <15
years old into the model. We used the Cook–Weisberg test22 to
assess for and to confirm heteroskedasticity (where subsamples
have different distributions) in the data used. As a consequence of
this heteroskedasticity, robust standard errors were included in the
regression models. This methodology has been widely used in similar
health-economics studies, and is regarded as a statistically robust
and conservative approach.8,23,24
Our fixed effects statistical model was therefore
Hi,t  Hi,0 ¼ þ ðUi,t  Ui,0Þþ t þ "i,t ,
where i is country and t is year; H is the health metric (breast cancer
mortality); U is the measure of unemployment;  represents the
population structure of the country being analysed,  is a dummy
variable for each country included in the regression model and " is
the error term.
To determine how PSEH modified the association between un-
employment and breast cancer mortality, the analysis was re-run
keeping unemployment as the predictor variable, with increases in
PSEH introduced as a control variable. The analysis was then
repeated using PSEH as the predictor variable and breast cancer
mortality as the response variable.
We conducted 1-, 2-, 3-, 4-, 5- and 10-year time-lag multivariate
analyses to quantify the long-term effects of changes in unemploy-
ment may have on breast cancer mortality. Several robustness checks
were also conducted; these are detailed in the results section.
Stata SE version 12 was used for the analysis (Stata Corporation,
Texas, USA).
Results
Unemployment
Table 2 shows the results of five regression models for 27 EU
countries between 1990 and 2009 after correcting for population
size, demographic structure and country-specific differences in
infrastructure.
A 1% rise in unemployment was associated with a statistically
significant increase in breast cancer mortality [P< 0.0001, coefficient
(R) = 0.1829, 95% confidence interval (CI) 0.0978–0.2680]. Using
current EU population estimates,25 this correlated with 1148
additional deaths across the region for each 1% rise in
unemployment, without incorporating lagged or long-term effects
of changes in unemployment. Lag analysis showed a continued
increase in breast cancer mortality at 1 year (P< 0.0001,
R = 0.2232, 95% CI 0.1333–0.3130); 3 years (P< 0.0001,
R = 0.2568, 95% CI 0.1531–0.3606); 5 years (P< 0.0001,
R = 0.2649, 95% CI 0.1647–0.3651); and 10 years (P< 0.0001,
R = 0.1825, 95% CI 0.0987–0.2663) after an increase in
unemployment.
Public-sector expenditure on health care
Including PSEH (measured as a percentage of GDP) as a control in
the above multivariate regression analyses removed the significant
association between unemployment and breast cancer mortality
(P= 0.063, R = 0.080, 95% CI 0.004 to 0.163). Notably, the
sample size and degrees of freedom in the analysis were also
decreased.
Multiple regression analysis, controlling for population size,
demographic structure and country-specific differences in infra-
structure, showed that a 1% rise in PSEH was associated with a
statistically significant decrease in breast cancer mortality
(P< 0.0001, R =1.28, 95% CI 1.67 to 0.877).
Robustness checks
To determine the robustness of our findings we conducted a series of
further analyses. First, we introduced additional economic variables
into the model to better isolate the impact of unemployment,
controlling for inflation, government debt as a percentage of GDP,
interest rates and changes in GDP per capita (Table 3).
Unemployment rises continued to be associated with increases in
breast cancer mortality (P= 0.0307, R = 0.1021, 95% CI 0.0096–
0.1946). Second, we introduced additional infrastructure variables,
controlling for urbanization, access to water, nutrition (mean calorie
intake). Despite a reduction in sample size and loss of degrees of
freedom due to the additional controls, unemployment rises
continued to be associated with increases in breast cancer
mortality (P= 0.0001, R = 0.1967, 95% CI 0.0978–0.2955). Third,
we controlled for differences in total spending on health care per
capita between countries (measured in US dollars; composed of
public and private sources of spending). Unemployment rises
continued to be associated with increases in breast cancer
mortality (P= 0.0081, R = 0.0999, 95% CI 0.0262–0.1736). Finally,
we re-ran the original multivariate regression using an alternate
source breast cancer mortality data—the EUREG European Cancer
Registry.26 Unemployment continued to be associated with increases
in breast cancer mortality (P= 0.0011, R = 0.1551, 95% CI 0.0625–
0.2476).
Discussion
Findings
We have shown that rises in unemployment in the EU are associated
with increased breast cancer mortality both in the short- and long-
term. This association remained after controlling for infrastructure
and economic indicators, but was removed when accounting for
PSEH. We have also shown that reduced PSEH is associated with
increased breast cancer mortality.
Possible mechanisms
The mechanism through which unemployment leads to worsening
breast cancer mortality is not yet established in the literature. We
observed both short- and long-term associations between loss of
employment and breast cancer mortality in our time-lag analyses.
We propose that the documented relationship between long-term
unemployment, low SES and breast cancer15–17,27–29 may be the
means by which unemployment changes have a ‘scarring’ effect on
Table 2 Multiple regression and lag analysis
Number of years
after 1% rise in
unemployment
Breast cancer mortality per 100 000
Coefficient P value Lower
confidence
interval
Upper
confidence
interval
Year 0 (year of change
in unemployment)
0.1829 0.0000 0.0978 0.2680
Year 1 0.2232 0.0000 0.1333 0.3130
Year 2 0.2326 0.0000 0.1357 0.3296
Year 3 0.2568 0.0000 0.1531 0.3606
Year 4 0.2798 0.0000 0.1721 0.3874
Year 5 0.2649 0.0000 0.1647 0.3651
Year 10 0.1825 0.0000 0.0987 0.2663
The impact of annual changes in unemployment on breast cancer
mortality, controlling for population size, population structure
(proportion of population <14 years of age, proportion of
population >65 years of age) and controlling for inter-country dif-
ferences in health-care infrastructure in addition to political,
cultural and structural differences (by introducing dummy
variables for each of the 27 EU countries).
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mortality that persists long after initial periods of unemployment
rises.
In the short to medium term, we suggest a number of mechanisms
through which mortality may relate to changes in unemployment.
Job loss has been associated with high levels of psychological
problems and harmful behaviours, in part due to reduced access
to health care, which can arise through an inability to pay for
transport, for example.4–6 As a consequence of this, treatment or
diagnosis of breast cancer may well be delayed, thus entailing an
increased risk of mortality. In our analyses, the association
between unemployment and breast cancer mortality was present
even when controlling for urbanization, access to water and
nutrition (calorie intake).
Our analyses also implicate PSEH as an important moderator of
the relationship between change in unemployment and breast cancer
mortality. Consistent with country-comparison study results30 we
found PSEH to be closely associated with breast cancer mortality.
The breast cancer care pathway is multidisciplinary and can be
costly, involving screening, radiotherapy, pharmacotherapy and
breast surgery, with associated reductions in mortality.31–34
Therefore, by increasing or maintaining access to health care for
those who have lost their jobs, elevations in PSEH may negatively
influence rates of breast cancer mortality.
Policy implications
Collectively, these findings have several policy implications. First,
from a population health perspective, we highlight the need for
public health input to economic policy development, to protect
and maintain population health, specifically, in this case, breast
cancer mortality. Based on our analyses, this could be achieved
through policies supporting re-employment or those aiming to
maintain or increase PSEH during economic downturns and rises
in unemployment. The need for this is highlighted by economic
forecasts that suggest that in EU member states such as the UK,
unemployment rates are unlikely to return to pre-recession levels
until after 2017.35
Second, our work suggests that policy interventions and fiscal
consolidation measures exacerbating unemployment while also
reducing PSEH or failing to compensate for reductions in private-
sector and out-of-pocket health-care expenditure,6,36 are likely to see
reductions in total health-care expenditure and, subsequently,
increases in breast cancer mortality in the EU. Indeed, some
economists have suggested that recent European fiscal consolidation
policies have been economically damaging.37,38 Our results extend
this argument to the public-health sphere. Moreover, the ‘troika’
[the EU, the European Central Bank (ECB) and the IMF] have
influenced the economic and fiscal policies of EU member states
most affected by the economic crisis (Cyprus, Greece, Ireland,
Portugal and Spain) with a view to control public-sector debt
levels through implementation of fiscal consolidation programmes,
frequently at the expense of higher unemployment.39 Our findings
lead us to question, from a public-health perspective, the merit of
these policies.
Limitations and advantages of the study
It is important to note the limitations of this study. First, we
evaluated population health outcome and economic trends at the
multinational level when, in fact, important unemployment
variations exist at regional and subnational levels.29 Although
national studies in this sphere have been conducted, our analysis
provides important insights across a European population, serving
of relevance to multinational policy development by agencies such as
the IMF, EU and ECB. We were also unable to model intra-year
variations in the level of unemployment. Second, we were unable to
control for specific aspects of the breast cancer care pathway such as
screening, which, as discussed, is likely to play a role in the identified
association. Third, for reasons of data availability, we were unable to
analyse the effects of the recent Great Recession from 2010 onwards.
However, in addition to recessions during the early 1990s and 2000s,
our analysis was still able to capture the effects of the earlier stages of
the Great Recession during which unemployment levels in some
countries peaked. Finally, because breast cancer is not as aggressive
as some other cancers, a longitudinal panel study that accounted for
secular, falling breast cancer mortality rates during the study period
would help elucidate the empirical induction period required to see
the impact that changes in unemployment and PSEH have on
avoidable breast cancer mortality.
Nevertheless, our study investigated the effect of unemployment
rises on breast cancer mortality with 30 controls for inter-country
variations, using numerous robustness checks. These checks and the
incorporation of robust standard errors allowed us to account for
the heterogeneity in the unemployment dataset owing to differences
in the way that countries measured unemployment rates, along with
factors such as underemployment or social programmes (for
example, back-to-work initiatives or programmes that see people
move from employment into education or training) that may
otherwise have hidden or suppressed actual unemployment rates.
As such, these checks allowed us to satisfactorily identify trends
over time across the region.
Table 3 Robustness checks
Robustness
check
Controls used in multiple
regression
Total number of
controls in
regression
Coefficient P value Lower confidence
interval
Upper
confidence
interval
Economic
controls
Original analysis controls and
changes in GDP per capita,
inflation, government debt as
a percentage of GDP, interest
rates
34 0.1021 0.0307 0.0096 0.1946
Infrastructure
controls
Original analysis controls and ur-
banization, access to water,
nutrition (mean calorie intake)
37 0.1967 0.0001 0.0978 0.2955
Health
spending
per capita
Original analysis controls and
health spending per capita
(dollars)
31 0.0999 0.0081 0.0262 0.1736
EUREG
database
Original analysis controls, using
European Registry cancer
database
30 0.1551 0.0011 0.0625 0.2476
Multiple regression analyses were re-run using the controls in the original analysis (population size, proportion of population >65 years of
age, proportion <14 and 27 country controls), in addition to those mentioned in the table below. The data show the impact of a 1% rise in
unemployment, on breast cancer mortality, using the mentioned controls.
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Conclusions
The 2009 recession led to a rapid decline in the GDP of almost all
EU member states,25 and the economies of many countries have yet
to recover. This event has raised the question of how macroeco-
nomic variations may impact cancer outcomes. Our study has
shown that increases in aggregate unemployment are associated
with significantly worse breast cancer mortality in the EU, a link
that may be moderated by changes in PSEH. Our study may thus be
seen as a first examination of the important breast cancer-related
consequences of the economic crisis. Policy interventions and
austerity measures, which may increase unemployment and reduce
PSEH, are a key concern, possibly presenting additional barriers to
breast cancer management.
Conflicts of interest: None declared.
Key points
 We used cross-country panel-data multivariate regression
analysis to examine how increases in aggregate unemploy-
ment varied with breast cancer mortality in the EU.
 We then examined how PSEH modified this association, and
also examined how PSEH increases varied with breast cancer
mortality in the EU.
 Increases in unemployment were associated with increases in
breast cancer mortality, while controlling for PSEH removed
the positive association between unemployment and breast
cancer mortality. Increases in PSEH were associated with
reduced breast cancer mortality.
 A likely mechanism for these associations is reduced access
to care in times of high unemployment and reduced health-
care spending.
 To help avoid reductions in breast cancer mortality
during economic downturns, clinicians should facilitate
access to care for the unemployed, and policymakers
should seek to bolster employment levels and protect or,
possibly, increase PSEH to maintain total health-care
expenditure.
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Background: The population of Palestine comprises almost 200 000 Palestinians aged 60 or older. The purpose of
the study was to estimate disability-free life expectancy for Palestinians living in the West Bank and Gaza Strip and
to evaluate changes from 2006 to 2010. Methods: The study combined mortality data and prevalence of activity
limitation derived from the Palestinian Family Health Surveys carried out in 2006 and 2010. Based on questions
about the ability to perform five basic daily activities, disability-free life expectancy was estimated. Changes
between 2006 and 2010 were decomposed into contributions from changes in mortality and disability. Results:
Life expectancy at age 60 increased from 17.1 years in 2006 to 17.3 years in 2010 for men and from 18.7 years to
19.0 years for women. Disability-free life expectancy increased significantly, by 1.3 years for 60-year-old men (from
12.8 years to 14.1 years) and 1.8 years for 60-year-old women (from 12.6 years to 14.4 years). This increase was seen
in the Gaza Strip as well as in the West Bank. While the modest contribution of the mortality effect did not differ
between gender and regions, the strong contributions from the disability effects varied, being greatest for women
in the Gaza Strip. Conclusion: The significant increase in disability-free life expectancy for both genders is
remarkable and, to our knowledge, not seen in other low-income countries. This change may be due to
decreasing incidence of disability and greater recovery from disability as a result of better prevention, care and
rehabilitation of chronic diseases.
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Introduction
The number of Palestinians living in the continuously shrinkingland of Palestine in 2012 is 4.4 million, of which 2 million are
refugees, the majority living in camps.1 Since the state of Israel was
established in 1948, the Palestinian population has been living under
war conditions, occupation or dislodged from their native soil. The
situation has deteriorated because Israel aggravates the conflict by
extending restrictions on movement and access to resources,
markets and health services, resulting in continuing dependency of
donor financing.2
The imbalance between the lives of Palestinians and Israelis is
striking. According to the World Bank, gross national income per
capita in Palestine is 18 times less than that of Israel.3 In 2010,
the unemployment rate was 23.7% in Palestine (17.2% in the
West Bank and 37.8% in the Gaza Strip) 4 and 6.6% in Israel.5
Although life expectancy at birth is higher in Palestine than in
some Arab countries, it is 9 years shorter among Palestinians
than Israelis,6 and regardless of which indicator for welfare and
sustainability is chosen, the situation in the occupied society is
unfavourable and in stark contrast to the situation in the
occupying power.
The health and quality of life of the Palestinian population have
been described in several papers.7–13 The mortality pattern has
changed from infectious diseases to non-communicable diseases as
the main causes of death.14 Today, heart disease, stroke, diabetes and
cancer account for about one-half of the total deaths. Increasing
urbanization has entailed a transition from a rural to an urban
lifestyle with adverse changes in the risk profile.7 Smoking (among
men), poor dietary habits, sedentary lifestyle and obesity are now
highly prevalent among Palestinians living in Palestine (e.g. the
prevalence of obesity is  40%).8,15 In urban areas, which
represent about half of the population, diastolic blood pressure,
fasting blood glucose, cholesterol and triglycerides are significantly
higher than in the rural population.7 As a result, hypertension, heart
diseases, the metabolic syndrome, diabetes and cancer today are
common illnesses among Palestinians; for example, among the
growing number of 60-year-olds or older,  35% reported having
hypertension in 2006 and 25% reported having diabetes.11,16
Recently we found that expected lifetime with chronic disease at
the age of 20 increased from 2006 to 2010 both for Palestinian men
and women (from 15.1 to 17.1 years for men, and from 13.6 to 14.4
years for women), in both the Gaza strip and the West Bank.6 In
particular, the increase in expected lifetime with hypertension and
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